Immune Response fka IMNR (IMNR)

[shakerzzz]

IMNR>> •(52 range .02 to .85) plus cornell = 1 hellava run starting (JMHO) The Company has several important clinical milestones in the coming year which we believe could drive the stock higher. We believe its current valuation understates the company’s value and earnings power. We see a valuation gap with other comparable companies.

Financial Highlights




Valuation Metrics


Other Investment Metrics

Market Capitalization
$ 13.1 mn

52-week range
$0.02-$0.85

Shares Outstanding
Approx. 656.5 mn

Avg. Trading Vol.
8.2 million

I saw the two year chart and noticed cornell capital loaned them a million dollars back in aug 4, 2005 and crashed the stock

it is going to be a gazelle now >>> 1 year anniversary but from bottom to top > this chart is perfect for the newbies to divr in head first > jmho > MAY TAKE FEW WEEKS TO GET BACK ON TOP BUT IM LUVING INSIDER BUYING AND RECENT PHASE 2 EXPANSION ON HIV